ArticleFrontiers in oncology2024

Anlotinib in Chinese patients aged ≥70 years with advanced non-squamous non-small cell lung cancer without prior chemotherapy: a multicenter, single-arm pilot trial.

Da Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.